Healthcare Industry News: Medline
News Release - December 14, 2009
Medline and 3M Reach Agreement to Resolve ClaimsST. PAUL, Minn. & MUNDELEIN, Ill.--(HSMN NewsFeed)--Medline Industries, Inc., based in Mundelein, Illinois, and 3M Company, based in St. Paul, Minnesota, announced today that they have amicably reached an agreement resolving all claims between them based on allegations that each company made false claims in advertising promoting their respective surgical hand cleaners, Medlineís Sterilliumģ Rub and 3Mís Avagardô Surgical Hand Antiseptic. Both products are used by doctors, nurses and other health care providers in preventing infection. The terms of the partiesí agreement are confidential. The partiesí claims against one another, currently pending in the United States District Court for the Northern District of Ohio, will be dismissed.
About 3M Infection Prevention Division
The 3M Infection Prevention Division offers healthcare professionals leadership solutions to minimize the risks of healthcare-associated infections. Combining science and technology, 3M has introduced more than 40 distinct technology platforms and a comprehensive portfolio of quality products that help the healthcare industry define and address current infection prevention best practices. With its system of people, products and process, 3M Infection Prevention remains a trusted partner committed to helping customers lead the way in controlling the risk of infection. For more information, please visit: www.mmm.com/infectionprevention.
About Medline Industries, Inc.
Medline, the nation's largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended care facilities, surgery centers, home care dealers and agencies and other markets. Headquartered in Mundelein, ILL., Medline has more than 800 dedicated sales representatives nationwide to support its broad product line and cost management services.
Meeting the highest level of national and international quality standards, Medline is FDA QSR compliant and ISO 13485 registered. Medline serves on major industry quality committees to develop guidelines and standards for medical product use, including the FDA Midwest Steering Committee, AAMI Sterilization and Packaging Committee and various ASTM committees. For more information on Medline, visit our Web site, www.Medline.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsUmoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform
ABM Respiratory Care Raises US$10.3M in Series A Funding Round and Appoints Peter H. Soderberg as Chairman of the Board of Directors
Novo Ventures co-leads US $83m series C financing in Lava Therapeutics